Who Owns Relmada Therapeutics Stock?
NASDAQ: RLMDHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 94.66%
- Held by insiders
- 3.23%
- Institutional holders
- 159
- Institutions 94.7%
- Insiders 3.2%
- Public and other 2.1%
Who owns Relmada Therapeutics stock?
Institutional investors own about 94.7% of Relmada Therapeutics's shares, spread across 159 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 3.23% of RLMD.
The largest institutional holders are Jupiter Topco LLC (0.00%), Blackrock Inc. (75.07%) and Squadron Capital Management LLC (74.29%). Together, the top 10 institutions control 475.4% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their RLMD positions and 2 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of RLMD
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Jupiter Topco LLC | 11.16M | 0.00% | +100.0% |
| Blackrock Inc. | 7.43M | 75.07% | +475.9% |
| Squadron Capital Management LLC | 7.35M | 74.29% | -13.3% |
| Venrock Adviser, LLC | 6.84M | 69.18% | +41.3% |
| Spruce Street Capital LP | 6.39M | 64.60% | +2.1% |
| Adage Capital Partners GP L.L.C. | 4.76M | 48.14% | 0.0% |
| Vanguard Capital Management LLC | 4.46M | 45.08% | +45.0% |
| Jones Hill Capital LP | 3.66M | 36.94% | +966.4% |
| Orbimed Advisors LLC. | 3.63M | 36.70% | -23.0% |
| State Street Corporation | 2.52M | 25.45% | +605.1% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of RLMD
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.17M | 32.04% |
| iShares Trust-iShares Russell 2000 ETF | 2.40M | 24.24% |
| MUTUAL FUND SERIES TRUST-Eventide Healthcare & Life Sciences Fund | 1.86M | 18.78% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.20M | 12.18% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 1.04M | 10.47% |
| SPDR SERIES TRUST-State Street SPDR S&P Pharmaceuticals ETF | 892.38K | 9.02% |
| iShares Trust-iShares Russell 2000 Growth ETF | 872.25K | 8.82% |
| Franklin Strategic Series-Franklin Biotechnology Discovery Fund | 788.72K | 7.97% |
| AdvisorShares Trust-AdvisorShares Psychedelics ETF | 670.86K | 6.78% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 521.02K | 5.27% |
Frequently asked questions
Who is the largest shareholder of Relmada Therapeutics?
Jupiter Topco LLC is the largest institutional shareholder of RLMD, owning 0.00% of shares outstanding (11.16M shares) as of its latest 13F filing.
What percentage of Relmada Therapeutics is owned by institutions?
Institutions own about 94.7% of RLMD shares and 97.8% of the public float.
How much of Relmada Therapeutics do insiders own?
Insiders, such as officers and directors, own about 3.23% of RLMD shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.